Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may ...

Cardiac fibrosis impacts millions of patients and currently has no effective therapy. Stanford Cardiovascular Institute researchers have uncovered a new mechanosensing-based mechanism that reduces ...